Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Filamon LTD
PMV Pharmaceuticals, Inc
Convalife (Shanghai) Co., Ltd.
ViroMissile, Inc.
Replimune Inc.
Carevive Systems, Inc.
Carevive Systems, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
SystImmune Inc.
Daiichi Sankyo
EXoPERT
Adela, Inc
Second Life Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Var2 Pharmaceuticals
Varian, a Siemens Healthineers Company
Complement Theory Inc.
Shanghai Juncell Therapeutics
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
NantCell, Inc.
AstraZeneca
Tempus AI
Massive Bio, Inc.
Eli Lilly and Company
LigaChem Biosciences, Inc.
Sanofi
Travera Inc
Shanghai Escugen Biotechnology Co., Ltd
A2 Biotherapeutics Inc.
Novita Pharmaceuticals, Inc.
Gene Solutions
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Monopar Therapeutics
Monopar Therapeutics
Tempus AI
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
NextCure, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Singlera Genomics Inc.